Lv31
398 积分 2025-03-04 加入
Positioning Enzyme- and Transporter-Based Precipitant Drug-Drug Interaction Studies in Drug Design
3小时前
待确认
Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes
3小时前
已完结
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations
3小时前
已完结
STAT proteins in cancer: orchestration of metabolism
18天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
26天前
已完结
In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species
1个月前
已完结
Mechanism-based inactivation of cytochromes P450: implications in drug interactions and pharmacotherapy
1个月前
已完结
Revamping the pharmacokinetics of poorly soluble drugs using different formulations
2个月前
已完结
Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance Mechanisms
3个月前
已完结
Achieving a low human dose for targeted covalent drugs: Pharmacokinetic and pharmacodynamic considerations on target characteristics and drug attributes
3个月前
已完结
皖公网安备34019202002308
